Real-world effectiveness of lebrikizumab on pruritus in moderate-to-severe atopic dermatitis: preliminary data from a single-center, real-life experience.

IF 2.8 4区医学 Q1 DERMATOLOGY

Clinical and Experimental Dermatology Pub Date : 2025-09-08 DOI:10.1093/ced/llaf411

Luca Potestio, Cataldo Patruno, Francesca di Vico, Ludovica Lizzi, Maddalena Napolitano

引用次数: 0

查看原文本刊更多论文

lebrikizumab治疗中度至重度特应性皮炎瘙痒的实际有效性：来自单中心真实经验的初步数据

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Experimental Dermatology 医学-皮肤病学

CiteScore

3.20

自引率

2.40%

发文量

389

审稿时长

3-8 weeks

期刊介绍： Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.